在儿科传染性胃肠炎中使用酸酸盐
Yvan Vandenplas1, Koen Huysentruyt1
1KidZ Health Castle, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
Translational gastroenterology and hepatology
|February 12, 2026
概括
凝酸有效地减少了急性胃肠炎 (AGE) 的儿童的腹持续时间. 这种辅助疗法与口服补水溶液相结合,在24小时内显示出迅速的疗效.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 临床药理学 临床药理学
背景情况:
- 急性胃肠炎 (AGE) 导致胃肠粘液和上皮损伤.
- 除了口服补水外,辅助疗法对于减少儿科AGE的腹持续时间至关重要.
研究的目的:
- 审查和讨论在治疗儿科AGE时使用凝酸的证据.
- 评估凝酸对儿童的疗效和起作用的开始.
主要方法:
- 来自多个数据库 (MEDLINE,Embase,CINAHL,Cochrane,LILACS) 和灰色文献的数据的系统审查.
- 分析了几项涉及AGE儿童的临床试验,主要来自土耳其,意大利和罗马尼亚.
主要成果:
- 凝酸在12小时内显著减少了腹持续时间,改善了便的一致性.
- 观察到腹持续时间显著减少,其中一项试验显示2.0天与安慰剂 (3.75天) 相比 (P<0.001).
- 大多数试验都显示出有益的结果,尽管在波兰的一项研究中,与安慰剂相比,没有发现差异.
结论:
- 当与口服补水溶液 (ORS) 配合使用时,凝酸在治疗儿童传染性AGE方面是有效和快速的.
- 由于研究数据的当前地理分布,需要进一步研究发展中国家的等酸.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
277
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
277
Pharmacokinetics in Pediatric Patients: Drug Distribution
334
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism
246
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
246
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
310
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
310
What is the Immune System?
132.4K
Overview
132.4K


